XCAN:SW:SW-Xtrackers MSCI Canada ESG Screened UCITS ETF 1C CHF (CHF)

ETF | Others |

Last Closing

USD 71.83

Change

0.00 (0.00)%

Market Cap

USD 0.34B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CHDIV:SW UBS ETF (CH) - MSCI Switzerlan..

-0.01 (-0.04%)

USD 1,244,681.59B
SWICHA:SW UBS ETF (CH) – MSCI Switzerl..

+0.02 (+0.10%)

USD 226,274.25B
SWUSAH:SW UBS ETF (CH) – MSCI Switzerl..

+0.20 (+0.72%)

USD 226,274.21B
SWEUAH:SW UBS ETF (CH) – MSCI Switzerl..

N/A

USD 226,274.20B
RGLDS:SW Raiffeisen ETF Solid Gold A US..

+31.00 (+0.40%)

USD 134,034.93B
RGLDSH:SW Raiffeisen ETF Solid Gold H CH..

-8.00 (-0.15%)

USD 134,034.91B
RGLDOH:SW Raiffeisen ETF Solid Gold Ounc..

-5.60 (-0.34%)

USD 134,034.86B
RGLDO:SW Raiffeisen ETF Solid Gold Ounc..

+7.50 (+0.36%)

USD 134,034.85B
SPICHA:SW UBS ETF (CH) – SPI® (CHF) A..

+0.26 (+0.34%)

USD 131,872.43B
SPMCHA:SW UBS ETF (CH) – SPI® Mid (CH..

+0.66 (+0.58%)

USD 130,595.12B

ETFs Containing XCAN:SW

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.80% 76% C+ 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.80% 76% C+ 75% C
Trailing 12 Months  
Capital Gain 14.54% 66% D+ 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.54% 66% D+ 67% D+
Trailing 5 Years  
Capital Gain 33.24% 64% D 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 33.24% 64% D 68% D+
Average Annual (5 Year Horizon)  
Capital Gain 8.82% 81% B- 80% B-
Dividend Return 8.82% 80% B- 79% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 19.11% 11% F 18% F
Risk Adjusted Return 46.17% 41% F 46% F
Market Capitalization 0.34B 51% F 47% F

Annual Financials (CHF)

Quarterly Financials (CHF)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.